J Am Pharm Assoc (2003). 2023 May-Jun;63(3):933-938. doi: 10.1016/j.japh.2023.02.017. Epub 2023 Feb 25.
The transgender population has disparities and predictors of smoking unique from the general population. Although culturally tailored smoking cessation programs have been created for minority populations with increased burden of tobacco use, there are no such pharmacist-led smoking cessation interventions for transgender patients.
The objective is to describe the development and implementation of a culturally tailored smoking cessation program for transgender and gender diverse patients and highlight an opportunity for pharmacist involvement in the interdisciplinary health care team for trans patients.
The BreatheOut program was devised as a pharmacist-led smoking cessation program for transgender and gender diverse patients. The program was designed based on the PEN-3 model for centering cultural identity in behavior change and was administered in an ambulatory care setting at a community health center with integrated clinical pharmacists. Patients are offered pharmacotherapy for treatment of smoking cessation in accordance with guideline-directed therapy.
Preliminary evaluation of this program was conducted through a prospective, observational study. To assess long-term feasibility of the program, time spent at each visit was tracked to calculate cost using a pharmacy resident versus a clinical pharmacist to provide the service. The program was financially feasible when the cost of personnel time was compared with medical billing and pharmacy revenue.
This culturally tailored smoking cessation program for a population with a high burden of smoking was found to be feasible when administered by a pharmacy resident or clinical pharmacist. Preliminary data support expansion of this program and the use of a culturally tailored approach to smoking cessation in this population.
跨性别群体的吸烟状况和相关因素与普通人群不同。尽管已经为受烟草使用影响负担较重的少数群体制定了文化适应性戒烟计划，但针对跨性别患者，还没有这样的由药剂师主导的戒烟干预措施。
本研究旨在描述为跨性别和性别多样化患者开发和实施文化适应性戒烟计划的过程，并强调药剂师有机会参与跨性别患者的跨学科医疗团队。
BreatheOut 计划是一个由药剂师主导的跨性别和性别多样化患者戒烟计划。该计划是基于 PEN-3 模型设计的，该模型将文化认同置于行为改变的中心，在社区健康中心的门诊环境中，由具有综合临床药师的团队实施。根据指南指导的治疗方法，为患者提供治疗戒烟的药物治疗。
通过前瞻性、观察性研究对该计划进行了初步评估。为了评估该计划的长期可行性，我们跟踪了每次就诊所花费的时间，以计算使用药剂学住院医师与临床药师提供服务的成本。与医疗计费和药房收入相比，该计划在人员时间成本方面具有经济可行性。
为受吸烟影响负担较重的人群提供的这种文化适应性戒烟计划是可行的，无论是由药剂学住院医师还是临床药师实施。初步数据支持该计划的扩展，并在该人群中使用文化适应性戒烟方法。
